Article
The DHCQ/HCQ metabolic ratio and CYP2C8 Genotype are associated with lipid profile improvement in systemic lupus erythematosus patients treated with hydroxychloroquine.
Arthritis research & therapy - 17 Apr 2026
Zhao Xue, Xie Han, Shao Tengfei, Ge Weihong, Zhu Yizhun, Jin Ziyi, Sun Lingyun
Abstract excerpt
BACKGROUND: Hydroxychloroquine (HCQ) improves the lipid profile in patients with systemic lupus erythematosus (SLE). Whether the lipid profile-improving efficacy of HCQ relates to its metabolism by cytochrome P450 (CYP450) enzymes remains unclear. METHODS: In this prospective cohort study, 459 Chinese adult patients with SLE who had received stable HCQ therapy for at least 3 months were enrolled. The whole‑blood...
Topics
Join the communities discussing this publication.
